Cesar Ivan Elizalde-Barrera

Cesar Ivan Elizalde-Barrera

Auto-generated profile, based on publicly available information

Cesar Ivan Elizalde-Barrera

Hospital General de Zona Numero 30, Instituto Mexicano del Seguro Social, Eje 4 Sur, Av. Pdte. Plutarco Elías Calles 473, Col. Santa Anita, Alcaldía Iztacalco, C.P. 08300 Ciudad de México, Mexico; Hospital General de Ticoman, Servicios de Salud Publica de la Ciudad de Mexico, Plan de San Luis S/N, Col. Ticoman, Alcaldía Gustavo A. Madero, C.P. 07330 Ciudad de México, Mexico

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2019 in Diabetes Research and Clinical Practice
Verified
Journal Article
Closed access
CECesar Ivan Elizalde-Barrera
Cesar Ivan Elizalde-Barrera
ARAlberto Francisco Rubio-Guerra
Alberto Francisco Rubio-Guerra
JLJose Juan Lozano-Nuevo
Jose Juan Lozano-Nuevo
JOJose Luis Olvera-Gomez
Jose Luis Olvera-Gomez

11 October 2017 in Therapeutic Advances in Endocrinology and Metabolism
Verified
Journal Article
Open access
CECesar I. Elizalde-Barrera
Cesar I. Elizalde-Barrera
TETeresa Estrada-García
Teresa Estrada-García
JLJose J. Lozano-Nuevo
Jose J. Lozano-Nuevo
AGAna K. Garro-Almendaro
Ana K. Garro-Almendaro
CLCatalina López-Saucedo
Catalina López-Saucedo
ARAlberto F. Rubio-Guerra
Alberto F. Rubio-Guerra
Hyperuricemia leads to insulin resistance, whereas insulin resistance decreases renal excretion of uric acid. The aim of this study was to evaluate whether there is a correlation between serum uric acid levels with homeostatic model assessment (HOMA) 1 in nondiabetic patients. We evaluated 88 nondiabetic patients, in whom uric acid levels were measured, in all of them HOMA of β-cell function (HOMA 1B) and HOMA of insulin resistance (HOMA 1IR) scores were performed. Uric acid and the HOMA 1 values were correlated using the Pearson coefficient. We did not find any correlation between uric acid levels with both HOMA 1B (r = 0.102, p = 0.343), nor with HOMA 1IR (r = 0.158, p = 0.117). When patients were analyzed by sex, we found a significant correlation with HOMA 1IR (0.278, p = 0.01), but not with HOMA 1B (0.138, p = 0.257) in women. We found a correlation with HOMA 1B in men (r = 0.37, p = 0.044), but not with HOMA 1IR: 0.203, p = 0.283. The analysis performed based on body mass index did not show correlation in the patients with normal weight, (HOMA 1B r = 0.08, p = 0.5, HOMA 1IR = 0.034, p = 0.793), nor in the patients who were overweight (HOMA 1B: r = 0.05, p = 0.76, HOMA 1IR r = 0.145, p = 0.43). However, a significant correlation between uricemia with both HOMA 1B (0.559, p < 0.001), and HOMA 1IR (0.326, p < 0.05), was observed in obese patients. Our results suggest that serum uric acid levels seem to be associated with insulin resistance in women, and in obese patients, but not in nonobese men. Uric acid also modifies β-cell function in men and in obese patients.

1 November 2009 in Integrated Blood Pressure Control
Verified
Journal Article
Open access
PDF file
ARAlberto F Rubio-Guerra
Alberto F Rubio-Guerra
DCDavid Castro-Serna
David Castro-Serna
CBCesar I Elizalde Barrera
Cesar I Elizalde Barrera
LRLuz M Ramos-Brizuela
Luz M Ramos-Brizuela
Current concepts in combination therapy for the treatment of hypertension: combined calcium channel blockers and RAAS inhibitors Alberto F Rubio-Guerra1, David Castro-Serna2, Cesar I Elizalde Barrera2, Luz M Ramos-Brizuela21Metabolic and Research Clinic, 2Internal Medicine Department, Hospital General de Ticomán SS DF, México Recent guidelines for the management of hypertension recommend target blood pressures <140/90 mmHg in hypertensive patients, or <130/80 mmHg in subjects with diabetes, chronic kidney disease, or coronary artery disease. Despite the availability and efficacy of antihypertensive drugs, most hypertensive patients do not reach the recommended treatment targets with monotherapy, making combination therapy necessary to achieve the therapeutic goal. Combination therapy with 2 or more agents is the most effective method for achieving strict blood pressure goals. Fixed-dose combination simplifies treatment, reduces costs, and improves adherence. There are many drug choices for combination therapy, but few data are available about the efficacy and safety of some specific combinations. Combination therapy of calcium antagonists and inhibitors of the renin-angiotensin-aldosterone system (RAAS) are efficacious and safe, and have been considered rational by both the JNC 7 and the 2007 European Society of Hypertension – European Society of Cardiology guidelines for the management of arterial hypertension. The aim of this review is to discuss some relevant issues about the use of combinations with calcium channel blockers and RAAS inhibitors in the treatment of hypertension.Keywords: hypertension, calcium channel blockers, renin-angiotensin-aldosterone system inhibitors, fixed-dose combination, adherence

8 December 2016 in Therapeutic Advances in Cardiovascular Disease
Verified
Journal Article
Open access
ARAlberto F. Rubio-Guerra
Alberto F. Rubio-Guerra
AGAna K. Garro-Almendaro
Ana K. Garro-Almendaro
CECesar I. Elizalde-Barrera
Cesar I. Elizalde-Barrera
JSJuan A. Suarez-Cuenca
Juan A. Suarez-Cuenca
MDMontserrat B. Duran-Salgado
Montserrat B. Duran-Salgado
A total of 60 hypertensive patients were randomized in two groups; group LA received losartan/amlodipine (100/5 mg) once a day, whereas LH group received losartan hydrochlorothiazide (100/12.5 mg) once a day for 3 months. In both groups serum uric acid levels were measured at the beginning and end of the study. Patients were evaluated monthly for blood pressure (BP) and adverse events. Statistical analysis was performed with a two-way analysis of variance (ANOVA) for repeated measures. All patients experienced a significant reduction of BP to the same extent (LA 155/94 to 123/79, LH 157/92 to 124/78 mmHg, p > 0.05). In the LA group, serum uric acid decreased from 6.5 ± 1.6 to 4.6 ± 1.3 mg/ml (p = 0.0001), whereas in the LH group there was a nonsignificant increase from 5.82 ± 1.4 to 5.85 ± 1.5 mg/ml, (p = 0.936). When both groups were compared, we found a significant reduction (p < 0.00013) on serum uric acid levels in the LA group. Both combinations decrease BP values to the same extent, however, LA combination showed a reduction on serum uric acid levels, which may contribute to a reduction in the metabolic risk in hypertensive patients.

29 December 2023 in Current HIV Research
Verified
Journal Article
Closed access
PDF file
CECesar Ivan Elizalde-Barrera
Cesar Ivan Elizalde-Barrera
CJCarlos Virgilio Juarez-Mendoza
Carlos Virgilio Juarez-Mendoza
Background: HIV late-stage diagnoses have an important impact on mortality. Unfortunately, a significant number of patients are still diagnosed at late stages. On the other hand, the coronavirus disease 2019 (COVID-19) pandemic has created an unprecedented crisis in healthcare systems worldwide, including HIV care services. : The aim of this study was to compare time-trends in HIV late diagnosis, prevalence, and initial CD4 cell counts of newly diagnosed HIV-positive individuals at the entry to HIV care in a General Hospital in Mexico City and to assess the Covid-19 pandemic possible effects on late diagnosis prevalence. Methods: We retrospectively analyzed the data of HIV-infected patients (January 1999 to December 2021) to assess the prevalence of Late presentation (LP, CD4 count < 350 cells/mm3) and presentation with advanced HIV disease (AHIVD CD4 count < 200 cells/mm3). Differences across time were evaluated, focusing on years of the Covid-19 pandemic. Results: We included 348 newly diagnosed HIV-positive individuals, of which 255 (73.2%) patients entered into care with LP, and 158 (45.4%) were on AHIVD. The proportion of patients with LP and AHIVD decreased significantly across the study period. Nevertheless, we found an increase in this proportion in the years 2020 (70% and 53%) and 2021 (86% and 68%). Conclusion: Despite the progressive decrease in late diagnosis prevalence in our population, it remains high. Even more, our results documented a possible increase in the prevalence of late diagnosis associated with the COVID-19 pandemic. These findings highlight the need to prioritize interventions to evaluate and reverse pandemic effects on people living with HIV care.

1 November 2024 in Endocrine, Metabolic & Immune Disorders - Drug Targets
Verified
Journal Article
Closed access
PDF file
EIElizalde-Barrera Cesar Ivan
Elizalde-Barrera Cesar Ivan
ETEstrada-Garcia Teresa
Estrada-Garcia Teresa
LCLopez-Saucedo Catalina
Lopez-Saucedo Catalina
RFRubio-Guerra Alberto Francisco
Rubio-Guerra Alberto Francisco
RERamirez-Velasco Diana Elena
Ramirez-Velasco Diana Elena
Background: Obesity-linked insulin resistance (IR) is an important risk factor for metabolic diseases, and anthropometric indices are commonly used for risk assessment. Aim: The study aimed to assess possible differences between women and men in the predictive value and association of nine obesity indices with IR, as assessed by HOMA-IR, in a nondiabetic adult population. Methods: The cross-sectional study included individuals recruited from a hospital in Mexico City. Indices evaluated were waist circumference (WC), hip circumference (HC), body mass index (BMI), waist-to-hip ratio, waist-to-height ratio, visceral adiposity index, body adiposity index (BAI), relative fat mass (RFM), and conicity index (CI). Fasting plasma glucose and insulin were measured to calculate HOMA-IR. Correlation analysis was performed between obesity indices and HOMA-IR. Receiver operating characteristics curve analyses were performed to determine predictive accuracy and cut-off values of obesity indices for IR. A binary logistic regression (BLR) analysis with OR calculation was performed to determine the strength of association with HOMA-IR. Results: We included 378 individuals (59% females, mean age 46.38 ±12.25 years). The highest Pearson coefficient value was observed for BMI among women, while among men, the highest values were found for BMI and BAI. WC among women, and BAI and RFM among men showed the highest sensitivity, while the highest specificity was observed for WHR among women and WC among men with respect to insulin prediction. In the adjusted BLR model, BMI, WC, and WHR among women and WC and RFM and BAI among men were independently associated with IR, showing the highest odds ratio (OR). Conclusion: In Mexican adults, WC, WHR, RFM and BAI could be complementary tools for BMI in screening for IR.